Clinical Trials on Recurrent Malignant Testicular Germ Cell Tumor
Total 8040 results
-
University of BirminghamUniversity of Leeds; Jazz Pharmaceuticals; The Brain Tumour CharityRecruitingGlioblastoma | Brain Tumor | Cannabis | Brain Tumor, RecurrentUnited Kingdom
-
Peter MacCallum Cancer Centre, AustraliaCompletedMalignant Rectal Neoplasm | Recurrent TumorAustralia
-
University of California, San FranciscoNovartis Pharmaceuticals; Pacific Pediatric Neuro-Oncology Consortium; The Pediatric...Active, not recruitingPediatric Recurrent Progressive Low-grade Gliomas | Pediatric Progressive Low-grade GliomasUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Recurrent Plasma Cell Myeloma | Caregiver | Recurrent LeukemiaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
First Affiliated Hospital of Zhejiang UniversityRecruiting
-
Fudan UniversityRecruitingMalignant MelanomaChina
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
Regeneron PharmaceuticalsCompleted
-
Aarhus University HospitalCompletedMalignant MelanomaDenmark
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable FundsCompleted
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Timmune Biotech Inc.The Second Affiliated Hospital of Hainan Medical University; Hainan Cancer...Unknown
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Inge Marie SvaneCopenhagen University Hospital at HerlevTerminated
-
American Regent, Inc.CompletedMalignant MelanomaUnited States
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
Scancell LtdTerminated
-
Hoffmann-La RocheCompleted
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Genentech, Inc.Terminated
-
Hoffmann-La RocheCompleted
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
Hoffmann-La RocheCompleted
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Oslo University HospitalCompleted
-
Gustave Roussy, Cancer Campus, Grand ParisTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance
-
Uppsala UniversityUppsala University HospitalCompletedMalignant MelanomaSweden
-
Medivation, Inc.CompletedMelanoma | Malignant MelanomaUnited States, Israel
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
University Hospital TuebingenCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBioNumerik Pharmaceuticals, Inc.Terminated
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
Mt. Sinai Medical Center, MiamiBayer; Chiron CorporationCompletedMalignant MelanomaUnited States
-
MedImmune LLCCompletedMalignant MelanomaUnited States
-
SciBase ABCompleted
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
Rigshospitalet, DenmarkCompleted
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingNeuroendocrine Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Assiut UniversityCompletedOvarian Neoplasms | Germ Cell Tumors | ImmunohistochemistryEgypt